Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

These medications mimic the action of the natural GLP-1 hormone in the body, promoting insulin secretion ... and stress management strategies. The combination of medication and lifestyle coaching ...

LixiLan is a fixed-ratio combination of basal insulin glargine 100 units/ml – marketed on its own as Lantus - matched with the GLP-1 receptor agonist lixisenatide, the active ingredient in ...

or your HbA1c is still up and you’re on a GLP-1 or GIP/GLP-1 dual agonist, this could be a perfect combination. [Insulin icodec and GLP-1s] are both once a week, patients can just take them and ...

Weight-loss drugs can be life-changing for people who have struggled to lose weight, however, some people who take them ...

A real-world study finds cardiovascular and survival benefits from dual therapy in patients with type 2 diabetes.

Glucagon-like peptide-1 (GLP-1) agonists are a class of medications primarily used to treat type 2 diabetes. GLP-1s work by ...

After 8 months of this combination approach, average total body weight loss was 20.3%, and lean body mass increased by 15% from 59.6% to 68.5%. All patients remained adherent to the GLP-1 ...

Drugmakers feared that using the GLP-1 medications with insulin might raise the chance of dangerously low blood sugar events, or hypoglycemia, and were unwilling to take the risk of studying them ...